Cite
Juang LJ, Hur WS, Silva LM, et al. Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA. Blood. 2021;doi: 10.1182/blood.2021014559.
Juang, L. J., Hur, W. S., Silva, L. M., Strilchuk, A. W., Francisco, B., Leung, J., Robertson, M. K., Groeneveld, D. J., La Prairie, B., Chun, E. M., Cap, A. P., Luyendyk, J. P., Palumbo, J. S., Cullis, P. R., Bugge, T. H., Flick, M. J., & Kastrup, C. J. (2021). Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA. Blood, . https://doi.org/10.1182/blood.2021014559
Juang, Lih Jiin, et al. "Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2021014559
Juang LJ, Hur WS, Silva LM, Strilchuk AW, Francisco B, Leung J, Robertson MK, Groeneveld DJ, La Prairie B, Chun EM, Cap AP, Luyendyk JP, Palumbo JS, Cullis PR, Bugge TH, Flick MJ, Kastrup CJ. Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA. Blood. 2021 Dec 27; doi: 10.1182/blood.2021014559. Epub 2021 Dec 27. PMID: 34958662.
Copy
Download .nbib